Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®

NCT06904820 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT06904820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06904820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®
Lead sponsor
University Hospital, Limoges
Phase
Observational
Overall status
Recruiting
Start date
June 5, 2025
Completion date
June 5, 2035
Enrollment
2,300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

viral hepatitis